Evidence map›Paper›PMID 30073490›Full record

ArticleDrug safety2018

Potential Risk Window for Opioid Overdose Related to Treatment with Extended-Release Injectable Naltrexone.

Ingrid A Binswanger, Jason M Glanz

Open access · greenAbstract readComment
In one paragraph

Article in Drug safety, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. The United States opioid epidemic.Seminars in perinatology · 2019
    Review
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Ingrid A BinswangerInstitute for Health Research, Kaiser Permanente Colorado, PO Box 378066, Denver, CO, 80237-8066, USA. Ingrid.A.Binswanger@kp.org.ORCID http://orcid.org/0000-0001-8862-8078
Jason M GlanzInstitute for Health Research, Kaiser Permanente Colorado, PO Box 378066, Denver, CO, 80237-8066, USA.
Kaiser Permanente · US

Funding

The Safety and Impact of Expanded Access to Naloxone in Health SystemsR01DA042059 · NIDA · KAISER FOUNDATION RESEARCH INSTITUTE · PI BINSWANGER, INGRID A, GLANZ, JASON M · 2016 to 2020
$3.6M
NIDA NIH HHS R01 DA042059NIDA NIH HHS R01DA042059
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Drug OverdoseNaltrexoneAnalgesics, OpioidDelayed-Action PreparationsHumansOpioid-Related DisordersAnalgesics, OpioidDelayed-Action PreparationsNaltrexone

Identifiers

PMID30073490
PMCPMC6366853
OpenAlexW2886607618

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.